A variety of high potential collagen tissue engineering products (Xenografts) for multiple clinical applications are being developed.

Highly-purified type I collagen can be obtained from several sources such as tendon, skin and/or pericardium. From the latter, collagen fleece can be made which is already on the market as Jason® and applied to minor wounds in implantology, periodontology and oral surgery.


Products under the eColl® family include:

  • Bovine & porcine dermis
  • Bovine & porcine pericard
  • Porcine fleece
  • Bovine collaged based tubular
  • Flat scaffolds
  • Which are suited for applications that range from periodontology to wound/infection care.
  • From maxillofacial reconstruction to tissue regeneration, from gynaecology to urology.

Furthermore, EMCM has developed a method for a cost efficient and reliable technique for the manufacture of Ultra-pure type 2 bovine fibrillar collagen and is working on developing a variant of Atelocollagen, new sources of collagen and much more.

EMCM has developed a dental membrane for one of the global leaders in the dental market. The membrane functions as a barrier between soft and hard tissue. The product is derived from an animal source and is processed into a decellularised as well as delipidised sterile product for dental application. EMCM has incorporated a novel approach for cleaning and sterilisation of this membrane which involves supercritical carbon dioxide (scCO2). Currently, the manufacturing process is brought to a higher level by the transfer from a feasibility run to a validated manufacturing process. 

The eColl® products are in various stages of development and will be classified as a Medical Device (CE). 

Due to host material, scientific and technical limitations, all advantages of the eCOO® Technology platform may not be applicable to each product under eTiss®, eColl® & eNova® products.